SCHEMBL6510028

SCHEMBL6510028

O=C(O)Cc1c[nH]c2cc(Cl)cc(Cl)c12

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 3/20 0.73
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
KDM4E B2RXH2 2/20 0.53
MAPT P10636 2/20 0.53
POLB P06746 1/20 0.53
GAA P10253 1/20 0.53
THRB P10828 1/20 0.53
DNMT1 P26358 1/20 0.53
RECQL P46063 1/20 0.53
CASP6 P55212 1/20 0.53
MCL1 Q07820 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
TSHR P16473 3/20 0.45
CYP2C9 P11712 2/20 0.45
HPGD P15428 2/20 0.45
LMNA P02545 2/20 0.45
GLA P06280 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27569321 0.83 GPR17 (0.52) GPR17ALDH1A1MEN1KMT2ATDP1
SCHEMBL10719605 0.81 KDM4E (0.56) GPR17ALDH1A1MEN1KMT2ATDP1
SCHEMBL154385 0.81 ALDH1A1 (0.69) GPR17ALDH1A1MEN1KMT2ATDP1
SCHEMBL29580629 0.81 ALDH1A1 (0.69) GPR17ALDH1A1MEN1KMT2ATDP1
SCHEMBL9279939 0.80 GPR17 (0.62) GPR17GRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL7406980 0.78 GPR17 (0.60) GPR17ALDH1A1MEN1KMT2ATDP1
SCHEMBL7413409 0.78 GPR17 (0.60) GPR17ALDH1A1MEN1KMT2ATDP1
SCHEMBL9156619 0.78 GPR17 (0.60) GPR17MEN1KMT2ATDP1KDM4E
SCHEMBL734758 0.77 GPR17 (0.68) GPR17FBP1CYP2D6GPR84BACE1
SCHEMBL28273847 0.76 GPR17 (0.58) GPR17MAPTLMNAPKMGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103621505-A Application of halogenated indole-3-acetic acid as herbicide UNIV SOUTHEAST 2014-03-12 CN disclosed
US-20050203166-A1 Indole-3-acetic acid derivatives CANCER RESEARCH TECHNOLOGY LIMITED 2005-09-15 US disclosed
US-6890948-B1 Use of indole-3-acetic acid derivatives in medicine CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2005-05-10 US disclosed
EP-1296676-B1 USE OF INDOLE-3-ACETIC ACID DERIVATIVES IN MEDICINE CANCER REC TECH LTD (GB) 2004-01-28 EP disclosed
EP-1296676-A1 USE OF INDOLE-3-ACETIC ACID DERIVATIVES IN MEDICINE Cancer Research Technology Limited (GB) 2003-04-02 EP disclosed
WO-2002002110-A1 USE OF INDOLE-3-ACETIC ACID DERIVATIVES IN MEDICINE CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2002-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203166-A1 Indole-3-acetic acid derivatives ADCY3, GPR3, HCAR3 GPR17 1040/4885ALDH1A1 176/4885MEN1 3930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.